THE USE OF A TEC KINASE INHIBITOR, IBRUTINIB, FOR THE DEVELOPMENT OF IMMUNOTHERAPIES AGAINST CANCER AND LEISHMANIASIS.
Main Author: | |
---|---|
Language: | English |
Published: |
The Ohio State University / OhioLINK
2016
|
Subjects: | |
Online Access: | http://rave.ohiolink.edu/etdc/view?acc_num=osu1461200133 |